This was 1 year ago
LocationOnline
ProgrammesCINEA and European Commission's DG CLIMA are organising an online info day to present the 2023 demonstration project calls of the Innovation Fund on 7 December 2023.
Interested parties with knowledge of previous IF calls are hereby reminded of various changes introduced in the 2023 calls, which will receive special attention in this info session.
Eligible sectors include (but are not limited to):
The preliminary deadline for applying is 9 April 2024. You can find more information and register on the official announcement.
During this info day, information will be given concerning:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.